No Benefit for MRI-Guided Treat-to-Target Strategy in Rheumatoid Arthritis
Data do not support the use of an MRI-guided treat-to-target strategy for treating patients with rheumatoid arthritis.
All articles by Lauren Grygotis, Editor
ACR Calls for Safeguards Against Step Therapy for Part B Drugs
The ACR is urging CMS to adopt safeguards to protect Medicare Advantage beneficiaries from step therapy.
Pelvic Orientation From Standing to Sitting Adjusted by Global Spinal Alignment in AS
Pelvic orientation was adjusted by global spinal alignment in patients with ankylosing spondylitis.
Connective Tissue Disease-Associated Interstitial Lung Disease: Unmet Needs and Challenges
The American College of Rheumatology and Association of Physicians of Great Britain and Ireland have highlighted unmet needs and challenges of connective tissue disease-associated interstitial lung disease.
FDA Fast Track Designation Granted for Investigational Osteoarthritis Treatment
The FDA has granted Fast Track designation for GLPG1972/S201086 for the treatment of osteoarthritis.
Decreased Health, Social Service Utilization Among Immigrants Following 2016 Presidential Election
Health and social service utilization decreased in immigrant communities after the 2016 presidential election.
Large-Vessel Vasculitis Classification: Draft Criteria Presented at ACR/ARHP 2018
The ACR and EULAR have developed draft classification criteria for giant cell arteritis and Takayasu arteritis.
Positive Phase 3 Results With Filgotinib for Treatment-Resistant Rheumatoid Arthritis
Treatment with filgotinib over 24 weeks resulted in significant improvements in the signs and symptoms of RA among patients with inadequate response or intolerance to biologic DMARDs.
ACR/ARHP 2018: Researchers Debate Hydroxychloroquine Dosing in SLE
Experts at the 2018 ACR/ARHP Annual Meeting discuss whether hydroxychloroquine dosing should be more than 5 mg/kg in patients with systemic lupus erythematosus.
Genetic Risk Score May Lead to Earlier Ankylosing Spondylitis Diagnosis
The genetic risk score may have lower costs than current testing methods.
Next post in ACR 2018 Coverage
